Mid Cap Healthcare
Stocks Ranked by
Market Capitalization
Mid Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 152 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $697B.
The largest by market cap are Bio-Rad Laboratories Class A (BIO) at $9.9B, Oscar Health (OSCR) at $9.6B and Vaxcyte (PCVX) at $9.5B.
Among institutional investors, Definium Therapeutics (DFTX) drew the most net new fund positions in Q2 2026: 149 funds opened new positions, taking total fund holders up 115 (46%) quarter-over-quarter.
- Combined market cap: $697B across 152 stocks.
- Mid Cap: market cap between $2B and $10B.
- Largest constituent: Bio-Rad Laboratories Class A (BIO), $9.9B market cap.
- Most net new fund positions in Q2 2026: Definium Therapeutics (DFTX), +115 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.